BioCentury
ARTICLE | Clinical News

Alpha-1 Antitrypsin: Phase I/II started

October 25, 2010 7:00 AM UTC

Omni Bio began a Phase I/II trial in up to 50 newly-diagnosed Type I diabetics to evaluate AAT for 2 years. ...